arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences, Telecoms, Media and Technology

FT Digital Health Summit

Enhancing the Impact of Innovation through Collaboration

Berlin |
Speakers include:
Ilona Kickbusch

Ilona Kickbusch

The Graduate Institute Geneva

Tony  Young

Tony Young

NHS England

Kalle Killar

Kalle Killar

Ministry of Social Affairs, Estonia

Overview

Hospitals and health services are under increased pressure from escalating costs and growing demand. The ability to harness digital disruption is key to easing the strain and delivering more adaptable and efficient healthcare. Collaboration and change management can facilitate implementation and help overcome the barriers posed by issues of security, engagement and integration.

Where and how can digital technologies, devices and applications, and the data they produce, have the most meaningful impact? How can they be evaluated to assess their effectiveness in terms of cost savings and enhanced experiences and outcomes for patients? To what extent can innovation promote wellness and relieve the burden on services?

The FT Digital Health Summit, now in its fifth year, will answer these questions and many more as it explores ways to implement digital transformation and improve the impact of innovation. Discussion will delve deep into the constraints and opportunities and consider how patients, hospitals, providers, innovators, investors and regulators can work together to ensure that technology is efficient and consistent in meeting the evolving needs of patients and in sustaining high-value integrated care.

fallback
fallback Add to my Calendar 06/18/2019 08:00:0006/18/2019 18:30:00trueFT Digital Health SummitHospitals and health services are under increased pressure from escalating costs and growing demand. The ability to harness digital disruption is key to easing the strain and delivering more adaptable and efficient healthcare. Collaboration and change management can facilitate implementation and help overcome the barriers posed by issues of security, engagement and integration.Where and how can digital technologies, devices and applications, and the data they produce, have the most meaningful impact? How can they be evaluated to assess their effectiveness in terms of cost savings and enhanced experiences and outcomes for patients? To what extent can innovation promote wellness and relieve the burden on services?The FT Digital Health Summit, now in its fifth year, will answer these questions and many more as it explores ways to implement digital transformation and improve the impact of innovation. Discussion will delve deep into the constraints and opportunities and consider how patients, hospitals, providers, innovators, investors and regulators can work together to ensure that technology is efficient and consistent in meeting the evolving needs of patients and in sustaining high-value integrated care.FT-Digital-Health-Summit13daf0b394225bfa9dc0aed02237ee98MM/DD/YYYY

2018 Photos

fallback

Testimonials

"Excellent investment of time. Brought the right people together to address the challenging questions“

Bayer

"A great opportunity to make new connections”

Sanofi

“We have a huge challenge to address healthcare provision and Digital will play a key part. Great day to stimulate thinking”

NIHR

"Excellent opportunity to learn and network“

Boehringer Ingelheim

fallback

Speakers (4)

Ilona Kickbusch

Ilona Kickbusch

Director, Global Health Centre
The Graduate Institute Geneva

Ilona Kickbusch's key interests relate to the political determinants of health, health in all policies and global health. She established the Global Health Centre at the Graduate Institute for International and Development Studies in Geneva.  She advises countries on their global health strategies and trains health specialists and diplomats in global health diplomacy. She is engaged in developing a new focus for the centre on the governance of health in the context of digital transformation.

Professor Kickbusch is a member of the Global Preparedness Monitoring Board and the WHO High-Level Independent Commission on NCDS and is co-chair of UHC 2030. She acts as Council Chair to the World Health Summit in Berlin.  She has been involved in German G7 and G20 activities relating to global health and chairs the international advisory board for the development of the German global health strategy. She initiated the @wgh300 list of women leaders in global health. She is program chair of the leaders in health network SCIANA.

Professor Kickbusch was a key instigator of the Ottawa Charter for Health Promotion and WHOs Healthy Cities Network and recently advised on the WHO activities related to Promoting Health in the SDGs.  She was the director of the Global Health Division at Yale University School of Public Health and responsible for the first major Fulbright Programme on global health. She has recently been awarded the Cross of the Order of Merit of the Federal Republic of Germany (Bundesverdienstkreuz) in recognition of her "invaluable contributions to innovation in governance for global health and global health diplomacy".

Tony  Young

Tony Young

National Clinical Lead for Innovation
NHS England

Tony Young is a practicing frontline NHS surgeon, Director of Medical Innovation at Anglia Ruskin University, and has founded 4 Med-Tech start-ups. He has also co-founded the £500m Anglia Ruskin MedTech Campus.

In 2014 he was appointed as National Clinical Director for Innovation at NHS England and in February 2016 became the first National Clinical Lead for Innovation. In this role he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS, promotes economic growth through innovation and helps make the NHS the go to place on the planet for medical innovation. In 2015 he founded the NHS Clinical Entrepreneur programme. This has become the world’s largest entrepreneurial workforce development programme for clinicians and under the NHS Long Term Plan is set for a major expansion to include intrapreneurs as well as entrepreneurs.  In the 2019 New Year's Honours list Tony was awarded the OBE for services to clinical leadership.

Kalle Killar

Kalle Killar

Deputy Secretary General E-services and Innovation
Ministry of Social Affairs, Estonia

Kalle Killar has over 15 years of experience working in different positions in the international organisations (European Bank for Reconstruction and Development, European Commission) and in different ministries in Estonia. Throughout his career Kalle has gathered experience in different areas from EU agriculture policy to investment banking in London that allows him to adapt to changing environment and maintain a positive attitude with an ability to find innovative solutions in the age of wicked problems.  Kalle holds a MBA in Business Administration from the University of Tartu.

Richard di Benedetto

Richard di Benedetto

President
Aetna International

Richard di Benedetto was appointed as President, Aetna International, in 2013. Following the acquisition of Aetna by CVS Health, Richard will continue in his current role, and will serve on the CVS Health Executive Management Team.

In 2014, Richard successfully led the acquisition and subsequent integration of InterGlobal, which significantly expanded Aetna’s global reach and brought valuable service expertise to the business. Richard has also been instrumental in collaborating with health care systems, government entities and plan sponsors worldwide to design locally appropriate solutions and develop new products to improve health, increase quality and drive cost effectiveness. Since 2015, the company has significantly expanded its presence in the Middle East and South East Asia, most recently with the acquisition of Bupa Thailand.

Prior to joining Aetna International, Richard spent three years as Chief Executive Officer at Euromedic International, one of the largest private equity owned European providers of diagnostic services, laboratories and cancer treatment. Richard previously spent 15 years with GE Healthcare in a number of senior leadership roles, latterly as President and Chief Executive Officer of their Eastern and Africa Growth Markets. In 2018, Richard was also appointed as a director and non-executive chairman to SleepCogni, a UK-based patented medical device with early clinical data providing a combined diagnostic and treatment system capable of identifying and helping treat sleep disorders for clinicians.

Richard holds a master’s degree in economics from the Institut d’Etudes Politiques in Paris and began his career with the Econocom Group SA based in France and Germany.

fallback

Moderator (1)

Sarah  Neville

Sarah Neville

Global Pharmaceuticals Editor
Financial Times

Sarah Neville began her career on local and regional newspapers, eventually becoming political editor of the Yorkshire Post. In 1995 she was awarded the Laurence Stern Fellowship on the Washington Post. She joined the Financial Times in 2001 and has since held a series of senior roles, including Weekend News Editor, Analysis Editor, UK News Editor and public policy editor in 2011. She was appointed Pharmaceuticals Correspondent in 2016.

Advisory Board (4)

Eugene Borukhovich

Eugene Borukhovich

Global Head of Digital Health
Bayer

Eugene Borukhovich is a serial intra and entrepreneur currently serving as a Global Head of Digital Health (G4A) at Bayer. He is also an Entrepreneur in Residence at Personal Health Solutions (PHS) Capital, as well as an advisor to numerous digital health startups. Eugene enjoys mentoring startups and an avid blogger about innovation, digital health and startups. 

Denis Gilhooly

Denis Gilhooly

Chief Strategy Officer
Commonwealth Centre for Digital Health (CWCDH)

Denis Gilhooly has over thirty years of experience in the information and communications technology and global development.  He is currently Chief Strategy Officer, Commonwealth Centre for Digital Health (CWCDH), Founder & CEO, Global  He@lth 2030 Innovation Task Force and Co-Chair, Global Digital Health initiative 2030.  He has worked extensively in the public and private sectors as Executive Director, UN Digital Health Initiative, Executive Secretary, UN Broadband Commission for Digital Development, Director, ICT4D, UNDP, Executive Coordinator, UN World Summit on the Information Society, Executive Secretary, G8 Digital Opportunity Task Force, and Information Infrastructure Advise, World Bank. He was a Member of An Taoiseach’s two Advisory Committees on Telecommunications and ICT for the Government of Ireland and a Commissioner of the Global Information Infrastructure Commission.  Denis was Vice President, Business Development, Teledesic LLC (the Broadband Internet-in-the-Sky venture of Bill Gates and Craig McCaw), Media & Technology Director, The Wall Street Journal and Dow Jones & Co., and founding Editorial & Publishing Director, Communications Week International and The Networked Economy and Global Mobile Conferences. He is currently a principal within Global Partnership for Sustainable Development Data and was a member of the World Economic Forum Global Agenda Council on Digital Health.

Niklas Kramer

Niklas Kramer

Senior Policy Advisor
Federal Ministry of Health, Germany

Niklas Kramer has worked since 2016 as Senior Policy Advisor in the Federal Ministry of Health in the Directorate on Digitalisation and Innovation. Before he held positions at a German social policy forum and in the office of a Member of the German Federal Parliament. Mr Kramer studied Public Policy and European Studies with a focus on Social and European Policy in Erfurt and Frankfurt Oder, spending exchange semesters in Colchester (UK) and Wroclaw (Poland).

Chris  Sawyer

Chris Sawyer

Innovation Lead for Digital Health
Innovate UK

Chris Sawyer leads on digital health at Innovate UK and has over 30 years’ experience in the healthcare technology sector.  Chris has been instrumental in the development and management of market leading medtech solutions at the cutting edge of the medical technologies sector. Having worked for global market leading medical technology companies, Chris also went on to complement this work through his work with the NHS when supporting the development of new innovative technological solutions for NHS Innovation Hubs.

Innovate UK in part of UK Research and Innovation and is the UK's innovation agency. It funds, supports and connects innovative British businesses through a unique mix of people and programmes to accelerate sustainable economic growth

fallback

Agenda - 18th Jun

  • 8:00am
    Registration and networking
  • 8:50am
    Opening remarks from the chair

    Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 9:00am
    Opening address: Realising a shared vision for health
  • 9:20am
    Health leaders' panel: Collaboration as a catalyst for transformation

    Healthcare systems around the world are pursuing transformation in their quest to improve quality, access and affordability. The investor mix is changing as the digital health landscape evolves and matures and new players and partnerships emerge. Patients, insurers, innovators, regulators and investors are working collaboratively with healthcare providers to facilitate a smooth transition but how can diverse strategies be aligned to ensure meaningful impact and outcomes?

    • How are relationships and partnerships helping to navigate technological and cultural change toward digitalisation? What constraints are limiting the transition?
    • How are tech giants and start-ups forming alliances with providers and moving into the healthcare space?
    • What new skills and leadership models are needed to spearhead the transformation?
    • What can we learn from experiences of delivering digital interventions at scale?
  • 10:10am
    Keynote interview
  • 10:30am
    Networking break
  • 10:50am
    Hospital 4.0 discussion: Investing for the future

    From automated registration and diagnostic imaging to patient monitoring and robot-assisted surgery no area of the hospital will remain untouched by the wave of digital change. Unlocking the benefits of disruption is beset by challenges, not least those posed by issues of security, engagement and integration. This panel will explore how to avoid the pitfalls and achieve enhanced operational efficiency and quality of care.

    • What will the hospital of the future look like? How are digital technologies being integrated into ageing hospitals or being built into new facilities?
    • What do tech-enabled solutions offer in terms of value and secure investment?
    • How is AI changing the way healthcare is delivered?
    • Can the potential of a virtual hospital be realised?
    • How can robust and reliable infrastructure support operational efficiencies in the digital age?
  • 11:40am
    Fireside chat: Innovation’s route to market

    Technology developers face a challenging journey to bring their products to market. As well as engaging with multiple stakeholders they need to demonstrate safety and performance and steer through complex regulatory processes. Here we will shine a light on best practices for upscaling business and closing the gap between product development and adoption.

  • 12:00pm
    Spotlight session: The patient’s digital pathway: now it’s personal

    How can digital touchpoints be tailored to the individual when there are so many different needs and preferences? This discussion will focus on ways of connecting and personalising the patient’s journey to deliver new and better end-user experiences and customised health interventions.

    • What do patients want and how do they define value? To what extent can and should the patient be in control of their own information?
    • What is the reality of digital health when it comes to providing a seamless care experience?
    • Do we risk creating a chasm between the tech-savvy and ‘no smartphone’ individuals? How do different patient groups intersect with technology and how can acceptance and engagement be improved?
    • How is the focus on the patient influencing decision-making? What is being done to integrate the patient voice into the development phase of new technologies and services?
  • 12:40pm
    Lunch
  • 1:40pm
    Keynote address: Moving pharma into the digital era
  • 2:00pm
    Discussion panel: Digiceuticals – threat or opportunity?

    Here we will consider the realities and opportunities of digiceuticals and the extent to which they can take pharma beyond the pill. The discussion will explore how software interventions and pharma collaboration are helping to advance treatment and manage disease.

    • What role can digital therapeutics play in managing patient interactions and in future treatment models?
    • Meeting the need for regulatory approval and clinical validation: How do you establish criteria to demonstrate safety and effectiveness?
    • What new investment opportunities are emerging? What are the collaboration benefits for pharma and digital innovators?
  • 2:40pm
    Global conversation: closing the health divide

    In 2018 delegates at the WHO World Health Assembly agreed a resolution to prioritise the greater use of digital technologies to improve access to healthcare for those most in need around the world. This conversation will assess global progress in digital health adoption and in expanding the scope of services.

    • How can we extend the reach of digital health and move the global health agenda forward?
    • How do you decide which approaches will have the most significant impact and how can progress be monitored?
    • Can countries without incumbent systems leapfrog development and embrace digital health more swiftly than those with legacy services? What are the advantages of starting from the ground up?
  • 3:20pm
    Networking break
  • 3:40pm
    Keynote presentation
  • 4:00pm
    Cross-sector discussion: Enhancing the value and impact of data

    Data volumes are growing exponentially and there is an increasing drive to extract value and enhance the impact of data. Making sense and use of the huge amount of information being generated is all the more challenging as much of it exists in silos across the health spectrum. This session will home in on ways of creating and maintaining secure systems to support the capture, management, analysis and sharing of data.

    • What does value mean when it comes to data? How can the flow of information and extraction of insights be improved whilst resolving issues of ownership, standards, privacy and security?
    • In what ways are AI analytics and IoT connectivity facilitating insight generation and data sharing?
    • How can social media and non-medical data sources be leveraged? How are concerns about the ethical use of personal data being addressed?
  • 4:40pm
    Discussion panel: Promoting wellness - prevention as the best cure for healthcare

    Prevention is growing ever more critical as healthcare systems grapple with escalating costs and rising demand for their services. Efforts are focused on public health and empowering individuals to take more proactive control of their wellness, and so reduce the burden on services.

    • How can the benefits of digital preventative solutions be assessed and can they make a long-term difference?
    • How do you improve the impact of prevention on healthcare costs?
    • What can boost adoption and adherence rates for wellbeing management tools?
  • 5:20pm
    Concluding remarks
  • 5:30pm
    Drinks reception

Why Attend

  • Assess how patients are being empowered and further involved in the transformation of healthcare
  • Hear how collaborations between pharma and big tech are enriching the commercial viability of digital health
  • Meet and greet with the full array of industry stakeholders, from healthcare to technology, pharma to start-ups, regulation to government
  • Identify solutions in overcoming cyber security threats in digital health
  • Don’t get left behind - be part of a must-attend event mapping the continued transformation of healthcare
fallback

Who attends

FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years. 

The FT Digital Health Summit Europe will be attended by: 

- Pharmaceutical and biotechnology companies 
- Healthcare Providers
- Medical Device manufacturers 
- Health insurers
- Investment banks 
- Hospital Management
- Clinicians 

fallback

Fees

Ticket Type

Fee

Early Bird Ticket (Ends on 28 February)

€899+VAT

Standard Ticket

€999+VAT

fallback

PRESENTED BY (1)

The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT marks 130 years in 2018 with a record paying readership of more than 940,000, three-quarters of which are digital subscriptions. It is part of Nikkei Inc, which provides a broad range of information, news and services for the global business community.

Venue

Maritim proArte Hotel
Friedrichstraße 151
10117 Berlin
Berlin

Germany

Tel: +49 (0) 30 2033-5
Email: info.bpa@maritim.de

fallback

SPONSORSHIP OPPORTUNITIES

  • Gain access to 150 Senior Executives from the Digital Health Industry, who will be attending the event;
  • Brand alignment with the FT and its unrivalled credibility;
  • Demonstrate thought leadership around the current critical issues affecting the healthcare industry;
  • Benefit from sustained international visibility through our advertising and marketing campaigns

Joe Hames

Commercial Manager, Global Industries

T: +44 (0)207 873 4551

M: +44 (0)791 329 2038

E: joe.hames@ft.com

fallback

Contact Us

Alexsandra Silva
Media Partner and Press Enquiries
Financial Times
Joe Hames
Sponsorship Opportunities
Financial Times
Ailsa Matkevich
Speaking Opportunities
Financial Times
FT Live Delegate Services - EMEA
Delegate Booking and Registration Enquiries
Financial Times